[Date Prev][Date Next] [Thread Prev][Thread Next] [Date Index] [Thread Index]

TAT 2017: Registration and abstract submission is open now

Title: *|MC:SUBJECT|*
Join this highly targeted conference covering the most promising new drugs and cancer targets under development in early phase clinical and translational research, as well as drugs close to entering clinical development.
Register now
Call for abstracts
We invite you to submit your abstract for presentation at the TAT 2017 Congress. Abstracts on a wide range of topics in the field of targeted therapy for cancer are welcome. The deadline for abstract submission is January 6, 2017. Abstracts accepted for presentation will be published in an indexed oncology journal. 
Submit your abstract now
The home of phase 1 in oncology
Under the chairmanship of professor Jean-Charles Soria, Goustave Roussy Cancer Center, the plenary sessions of the 15th ‘International Congress on Targeted Anticancer Therapies’ will cover the following themes:
  • Opening Ceremony with TAT 2017 Honorary Award Lecture and Keynote Lecture
  • Immune-Oncology (1): Novel combinations and biomarkers
  • Immuno-oncology (2): Novel immune modulators
  • Phase 1 studies – Completed or in progress
  • Early-phase drug development in hematology
  • Targeting the cell cycle
  • Targeting cancer metabolism
  • Targeted drug delivery: Next-generation antibody-drug conjugates and nanoparticles
  • Clinical genomic profiling in early-phase clinical studies
  • New androgen receptor inhibitors in prostate cancer
  • New cytotoxic agents
  • Miscellaneous drugs and targets 
The poster sessions will provide an even wider range of topics in the field of targeted drug development and related areas of research. Check the list of abstract topics for more information on abstract and poster topics.
Key characteristics
  • Focus at early-phase development and translational research of new molecular and immunological targets
  • Invited lectures by top-level faculty, including phase 1 investigators having hands-on experience with the new agents
  • Highly international participation from across the globe
  • Medium-sized meeting offering plenary sessions only
  • Excellent networking opportunities in a confined setting
  • Accredited learning for medical specialists 
Organizing Committee
Jean-Charles Soria, FR; President
Giuseppe Giaccone, USA
Gail Eckhardt, USA
Lee Ellis, USA
Marinus Lobbezoo, NL
Josep Tabernero, ES
Alexander Eggermont, FR
Scientific Advisory Board
Michael Atkins, USA
Jean-Pierre Armand, FR
Udai Banerji, UK
Susan Bates, USA
Philippe Bedard, CAN
Hilary Calvert, UK
Filippo de Braud, IT
Kapil Dhingra, USA
Keith Flaherty, USA
Roch Houot, FR
David Hyman, USA
Jeffrey Infante, USA
Antoine Italiano, FR
Filip Janku, USA
Shivaani Kummar, USA
Ulrik Lassen, DK
Martijn Lolkema, NL
Patricia LoRusso, USA
Aurelien Marabelle, FR
Christophe Massard, FR
Peter O’Dwyer, USA
Arne Östman, SWE
Michael Pishvaian, USA
Ruth Plummer, UK
Yves Pommier, USA
Vincent Ribrag, FR
Jordi Rodon, ES
Gary Schwartz, USA
Lesley Seymour, CAN
Geoffrey Shapiro, USA
Anthony Tolcher, USA
Giorgio Trinchieri, USA
John Wright, USA
Marriott Rive Gauche Hotel & Conference Center
17 Boulevard Saint Jacques
Paris, 75014 France

Reply to: